Interesting Engineering on MSN
US team enrolls first patient to test nuclear medicine device for cancer treatment
The University of Missouri (Mizzou) in the US has reached a major milestone in ...
Gilead beats Q4 estimates on strong HIV and Liver Disease portfolio performance, but 2026 guidance tempers sentiment despite ...
Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune ...
Company advances its leadership in MASH with an expanded pipeline, which now includes more than 10 programs at multiple ...
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has shown that a single injection of an ...
CORALreef Lipids randomized 2,909 adults (2:1) to enlicitide 20 mg daily or placebo across 168 sites, using stratification by renal function, baseline statin use, and region. LDL-C at week 24 ...
The FDA accepted the New Drug Application for zanzalintinib plus atezolizumab for the treatment of adult patients with metastatic colorectal cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results